Company / Working Capital
Bausch & Lomb Corp Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.1B
FY2025
5-year range
$536.0M / $1.2B
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
#33 of 165
Health Care
What the data says
Bausch & Lomb Corp's working capital of $1.1B is higher than 80% of companies in the Health Care sector (FY2025). Declined from $1.2B to $1.1B over the past 2 years.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 3-year CAGR of +7.9%. Top quartile in the Health Care sector.
Declined from $1.2B to $1.1B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +7.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 165This company $1.1B Sector average $836.2M
▼
+26.4% above sector average
Key checks
Key Insights
- 3-year CAGR of +7.9%, indicating consistent growth.
- In FY2025, working capital increased 0.7% year-over-year.
- Ranks #33 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +0.7% |
| FY2024 | $1.1B | -9.7% |
| FY2023 | $1.2B | +38.3% |
| FY2022 | $841.0M | +56.9% |
| FY2021 | $536.0M | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026